Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Patrick Marcellin(Inserm), Edward Gane(Auckland City Hospital), Marı́a Buti(Vall d'Hebron Hospital Universitari), Nezam H. Afdhal(Beth Israel Deaconess Medical Center), William Sievert(Monash Medical Centre), Ira M. Jacobson(Cornell University), M. Kay Washington(Vanderbilt University), G. Germanidis(AHEPA University Hospital), John F. Flaherty(Gilead Sciences (United States)), Raul Aguilar Schall(Gilead Sciences (United States)), Jeffrey D. Bornstein(Gilead Sciences (United States)), Kathryn M. Kitrinos(Gilead Sciences (United States)), G. Mani Subramanian(Gilead Sciences (United States)), John G. McHutchison(Gilead Sciences (United States)), E. Jenny Heathcote(University of Toronto)
The Lancet
December 9, 2012
Cited by 1,774

Abstract


Related Papers

No related papers found

Powered by citation graph analysis